Leidos to Support Congressionally Directed Medical Research Programs Under Potential $98M Army Contract

Leidos (NYSE: LDOS) has received a potential five-year, $98 million contract from the U.S. Army to perform scientific and administrative services in support of Congressionally Directed Medical Research Programs.

The company said Thursday it will assist CDMRP leaders and government program managers as well as establish programmatic panels that will advise the government on potential uses of research funds.

CDMRP was founded in 1992 through a Congressional appropriation to develop novel biomedical research approaches that will address the needs of citizens, the military and Congress.

Leidos has supported CDMRP for 25 years and will perform work under the new contract in Frederick, Maryland.

The contract has a one-year base ordering period and four one-year optional ordering periods.

You may also be interested in...

research and development

$105M DOE R&D Funding Opportunity Opens for Small Businesses

The Department of Energy plans to award $105M in total research and development grants for the second phase of its fiscal 2021 Small Business Innovation Research and Small Business Technology Transfer initiatives.

Kevin Kelly advisory board member Enlightenment Capital

Former CACI Exec Kevin Kelly Joins Enlightenment Capital Advisory Board

Kevin Kelly, former president of the national security and innovative solutions sector at CACI International (NYSE: CACI), has been named an advisory board member at investment firm Enlightenment Capital. He brings more than 25 years of government services industry experience to the board and will support Enlightenment's portfolio companies in national security business growth efforts, the company said Monday.